You are here: Industry Insights > Merck

News List

As Merck Research Laboratories moves into new facility, 20 staffers get the ax fiercepharma
April 03, 2019
Merck is set to cut 20 staffers from its Research Laboratories unit as it prepares to enter its new digs in South San Francisco.
Merck’s KEYTRUDA receives approval in China biospectrumasia
April 02, 2019
Merck, known as MSD outside the United States and Canada, has announced that KEYTRUDA, Merck’s anti-PD-1 therapy,……
FDA green light for Merck's Mavenclad pharmatimes
April 02, 2019
German pharmaceutical giant Merck has announced the US Food and Drug Administration (FDA) approval of its Mavenclad (cladribine) tablets in various forms of multiple sclerosis (MS).
Merck's Keytruda, up for new FDA nod, spurs lengthy responses in small cell lung cancer fiercepharma
April 02, 2019
Merck & Co. is awaiting an FDA decision for Keytruda in previously treated small cell lung cancer, and it has new numbers to boost its case.
One year after mammoth lung cancer win, Merck's Keytruda holds its own in tough-to-treat subgroups fiercepharma
April 02, 2019
ATLANTA—At last year’s American Association for Cancer Research annual meeting……
Merck's refreshed HPV vaccine push puts Mom in the spotlight fiercepharma
March 21, 2019
Merck & Co. has added a twist to its years-long HPV vaccine awareness campaign—and parents finally get a say.
Merck to collaborate with GenScript to accelerate cell and gene therapy industrialization in China worldpharmanews
March 20, 2019
Merck announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.
Merck collaborates with GenScript to accelerate the industrialization of cellular and genetic therapies in China pharmafocusasia
March 20, 2019
Merck , a leading science and technology company, today announced the signing of a non-binding Memorandum of Understanding with Chinese biotechnology company GenScript to form a strategic alliance with the aim of making plasmids and viral vectors.
Merck announces collaboration with Iktos for generative artificial intelligence (AI) technology worldpharmanews
March 19, 2019
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances.
CMA drops anti-competitive case against MSD pharmatimes
March 19, 2019
The Competition and Markets Authority (CMA) has closed its investigation into a suspected anti-competitive discount scheme developed by Merck Sharp & Dohme (MSD) after finding no grounds for action.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page